scispace - formally typeset
Journal ArticleDOI

Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system.

Reads0
Chats0
TLDR
The results suggest that the selective uptake by dopamine transporter may account for the specific neurotoxicity of (R)-1,2-DiMeDHTIQ to dopamine neurons.
Abstract
Uptake of catechol isoquinolines to dopamine cells was studied using human dopaminergic neuroblastoma SH-SY5Y cells. Only (R)-1,2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline [(R)-1,2-DiMeDHTIQ] was transported by dopamine uptake system, while (S)-1,2-DiMeDHTIQ, (R)- and (S)-1-methyl-6,7-dihydroxy-tetrahydroisoquinoline, and 1,2-dimethyl-6,7-dihydroxyisoquinolinum ion were not. Kinetical study showed that the uptake of (R)-1,2-DiMeDHTIQ followed the Michaelis-Menten equation, and the values of the Michaelis constant and the maximal velocity were obtained to be 102.6 +/- 36.9 microM and 66.0 +/- 2.8 pmol/min/mg protein. Dopamine was found to inhibit (R)-1,2-DiMeDHTIQ uptake competitively. These results suggest that the selective uptake by dopamine transporter may account for the specific neurotoxicity of (R)-1,2-DiMeDHTIQ to dopamine neurons.

read more

Citations
More filters
Journal ArticleDOI

Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells

TL;DR: This model may be useful to perform large‐scale biochemical and molecular studies due to its susceptibility to genetic manipulation and the availability of an unlimited amount of cells.
Journal ArticleDOI

SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.

TL;DR: Evaluating the human neuroblastoma SH-SY5Y cell line as an in vitro model of dopaminergic (DAergic) neurons for Parkinson's disease (PD) research and the effect of differentiation on this cell model found some differentiating agents afford SH- SY5Y cells with more potential for studying neurotoxicity and neuroprotection and are thus more relevant to experimental PD research.
Journal ArticleDOI

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

TL;DR: The present contribution starts out by describing some of the clinical, pathological and neurochemical phenomena of Parkinson's disease, and hypotheses concerning the mechanisms of these neurotoxines have been related to the pathogenesis of nigral cell death in PD.
Journal ArticleDOI

Glycogen synthase kinase 3β (GSK3β) mediates 6-hydroxydopamine-induced neuronal death

TL;DR: It is demonstrated here that 6‐OHDA evoked endoplasmic reticulum (ER) stress, which was characterized by an up‐regulation in the expression of GRP78 and GADD153 (Chop), cleavage of procaspase‐12, and phosphorylation of eukaryotic initiation factor‐2 a in a human dopaminergic neuronal cell line (SH‐SY5Y) and cultured rat cerebellar granule neurons (CGNs).
Journal ArticleDOI

Rapamycin protects against rotenone-induced apoptosis through autophagy induction

TL;DR: In this study, rotenone-exposed human neuronal SH-SY5Y cells were used as an in vitro model to determine whether autophagy enhancer rapamycin could protect against roten one-induced injury and its underlying mechanisms and it was concluded that pharmacologically induction ofAutophagy by rap amycin may represent a useful therapeutic strategy as disease-modifiers in PD.
References
More filters
Journal ArticleDOI

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

TL;DR: This assay is very reproducible and rapid with the dye binding process virtually complete in approximately 2 min with good color stability for 1 hr with little or no interference from cations such as sodium or potassium nor from carbohydrates such as sucrose.
Journal ArticleDOI

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

TL;DR: Blockage of dopamine uptake by mazindol prevents MPTP-induced damage to nigrostriatal dopamine neurons, indicating that MPP+ concentration into dopamine neurons explains their selective destruction by MPTP.
Journal ArticleDOI

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

TL;DR: The neurotoxic chemical MPTP is metabolized by rat brain mitochondrial fractions at a rate of 0.91 +/- 0.02 nmoles/mg protein/min, and the major metabolite has been identified as the 1-methyl-4- phenylpyridinium species.
Journal ArticleDOI

Pargyline prevents MPTP-induced parkinsonism in primates.

TL;DR: Treatment of squirrel monkeys with pargyline prevents both clinical and neuropathological evidence of the neurotoxic effects of MPTP, and it is proposed that the conversion of MP TP to MPP+, possibly involving MAO, may be important for the neurot toxic effects to take place, and MPTP itself may not be the neurotoxicity agent.
Journal ArticleDOI

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

TL;DR: The results suggest that TIQ is one of the candidates of neurotoxins to produce parkinsonism.
Related Papers (5)